BOSTON SCIENTIFIC CORP

Income statement revenue $5.44B (+7.5% YoY).Operating income $1.18B (+43.8% YoY).Pre-tax result $1.06B (+12.6% YoY).Net result $905M (+13.8% YoY).

• Cardiac Rhythm Management: $585M (-0.8% YoY)
• Electrophysiology EP: $916M (+9.0% YoY)
• Global Endoscopy Endo Reporting Unit: $793M (+7.6% YoY)
• Global Neuromodulation Nm Reporting Unit: $341M (+12.5% YoY)
• Global Urologyand Pelvic Health Reporting Unit: $684M (+1.2% YoY)
• Interventional Cardiology Therapies: $1.33B (+13.2% YoY)
• Interventional Oncology And Embolization: $283M (+12.7% YoY)
• Watchman: $507M (+4.3% YoY)
• Operating costs: $2.67B
• Other expense: $118M
• Income tax expense: $155M (+6.2% YoY)